Snapshot from Apr 21, 2026 at 07:00 UTC. For live data and tracking: View Live
Entities / Helen Knight
Person

Helen Knight

Tracked across 1 events · 8 articles · First seen Mar 31, 2026 · Last active Apr 01, 2026

Sentiment
50
Attention
4
Events
1
Relationships
0
Live sentiment trends, attention charts, and prominence tracking available on the NewsDesk Dashboard
Events (1)
4 50
Regulatory
UK Approves Semaglutide for Heart Disease
Helen Knight, as director of medicines evaluation at the United Kingdom===National Institute for Health and Care Excellence, played a key role in the decision to approve Semaglutide, highlighting the compelling evidence from clinical trials.
Mar 31, 2026 · 8 articles
NEWSDESK
Track Helen Knight live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About NewsDesk

NewsDesk is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.newsdesk.dev.